Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Brad Anderson, PhD

Cancer Center Member

brad anderson

Research Programs:
Translational Oncology

Colleges & Departments:
College of Pharmacy, Department of Pharmaceutical Sciences

Faculty Rank:

Research Focus

Drug development and drug delivery systems.

Contact Information

University of Kentucky
Lexington, KY 40536
United States


  1. Influence of Chain Ordering on the Selectivity of DPPC Bilayer Membranes to Permeant Size and Shape. T.-X. Xiang and B.D. Anderson. Biophysical J., 75, 2658-2671 (1998).
  2. Liposomal Delivery of Hydrophobic Weak Acids: Enhancement of Drug Retention Using a High Intraliposomal pH. V. Joguparthi and B.D. Anderson. J. Pharm. Sci., 97, 433-454 (2008).
  3. A Mechanism-Based Kinetic Analysis of Succinimide Mediated Deamidation, Racemization, and Covalent Adduct Formation in a Model Peptide in Amorphous Lyophiles. M.P. DeHart and B.D. Anderson. J. Pharm. Sci., 101, 3096-3109 (2012).
  4. Anderson, Insights Into Accelerated Liposomal Release of Topotecan in Plasma Monitored by a Non-invasive Fluorescence Spectroscopic Method. K.D. Fugit, A. Jyoti, M. Upreti, and B.D. J. Control. Rel., 197, 10-19 (2015).
  5. Anderson, Determination of Key Parameters for a Mechanism-Based Model to Predict Doxorubicin Release from Actively-Loaded Liposomes. E. Csuhai, S. Kangarlou, T.-X. Xiang, A. Ponta, P. Bummer, D. Choi, and B. D. J. Pharm. Sci., 104, 1087-1098, (2015).


Research Equipment